---
title: "RBC Capital Reaffirms Their Buy Rating on AstraZeneca (AZN)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298372812.md"
description: "RBC Capital analyst Trung Huynh maintained a Buy rating on AstraZeneca today and set a price target of £145.00. According to TipRanks, Huynh is a 5-star analyst with an average return of 22.7% and a 75.69% success rate. Huynh covers the Healthcare sector, focusing on stocks such as Bristol-Myers Squibb, Merck & Company, and Pfizer. In addition to RBC Capital, AstraZeneca also received a Buy from Barclays’s James Gordon CFA in a report issued yesterday. However, today, Deutsche Bank maintained a Sell rating on AstraZeneca (LSE: AZN)."
datetime: "2026-09-08T22:07:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298372812.md)
  - [en](https://longbridge.com/en/news/298372812.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298372812.md)
generator: "portal-rs"
---

# RBC Capital Reaffirms Their Buy Rating on AstraZeneca (AZN)

RBC Capital analyst Trung Huynh maintained a Buy rating on AstraZeneca today and set a price target of £145.00.

According to TipRanks, Huynh is a 5-star analyst with an average return of 22.7% and a 75.69% success rate. Huynh covers the Healthcare sector, focusing on stocks such as Bristol-Myers Squibb, Merck & Company, and Pfizer.

In addition to RBC Capital, AstraZeneca also received a Buy from Barclays’s James Gordon CFA in a report issued yesterday. However, today, Deutsche Bank maintained a Sell rating on AstraZeneca (LSE: AZN).

### Related Stocks

- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [AZN.UK](https://longbridge.com/en/quote/AZN.UK.md)
- [RY.US](https://longbridge.com/en/quote/RY.US.md)
- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [BARC.UK](https://longbridge.com/en/quote/BARC.UK.md)
- [BCS.US](https://longbridge.com/en/quote/BCS.US.md)
- [DBK.DE](https://longbridge.com/en/quote/DBK.DE.md)
- [DB.US](https://longbridge.com/en/quote/DB.US.md)
- [CELG.RT.US](https://longbridge.com/en/quote/CELG.RT.US.md)
- [03KB.DE](https://longbridge.com/en/quote/03KB.DE.md)
- [DPB.DE](https://longbridge.com/en/quote/DPB.DE.md)

## Related News & Research

- [AstraZeneca: SERENA-4 Trial Of Etcamah Palbociclib Combination Fails To Meet Primary Objective](https://longbridge.com/en/news/298875452.md)
- [Deutsche Bank  Sticks to Its Sell Rating for AstraZeneca (AZN)](https://longbridge.com/en/news/298313802.md)
- [AstraZeneca COPD Drug Cuts Exacerbations as FDA Priority Review Nears](https://longbridge.com/en/news/298828016.md)
- [Astrazeneca Plc (NYSE:AZN) Receives Consensus Recommendation of "Moderate Buy" from Brokerages](https://longbridge.com/en/news/299278211.md)
- [HB Wealth Management LLC Invests $4.90 Million in Astrazeneca Plc $AZN](https://longbridge.com/en/news/298284395.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**